Fixed-dose combination
Nystatin and Triamcinolone acetonide is a fixed-dose combination of a corticosteroid and a polyene antifungal indicated for the treatment of cutaneous candidiasis, among other approved uses. MedsAcross supplies Nystatin and Triamcinolone acetonide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Nystatin and Triamcinolone Acetonide Cream is indicated for the treatment of cutaneous candidiasis, it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.
Source: US FDA prescribing information
Nystatin and Triamcinolone Acetonide Cream is usually applied to the affected areas twice daily in the morning and evening by gently and thoroughly massaging the preparation into the skin. The cream should be discontinued if symptoms persist after 25 days of therapy. Nystatin and Triamcinolone Acetonide Cream should not be used with occlusive dressings.
Source: US FDA prescribing information
These preparations are contraindicated in those patients with a history of hypersensitivity to any of their components.
Source: US FDA prescribing information
A single case (approximately one percent of patients studied) of acneiform eruption occurred with use of combined nystatin and triamcinolone acetonide in clinical studies. Nystatin is virtually nontoxic and nonsensitizing and is well tolerated by all age groups, even during prolonged use. Rarely, irritation may occur. The following local adverse reactions are reported infrequently with topical corticosteroids (reactions are listed in an approximate decreasing order of occurrence): burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, perioral secondary infection, skin atrophy, striae and miliaria. or https://www.fda.gov/Safety/MedWatch/
Source: US FDA prescribing information
Store at 20° to 25°C (68° to 77°F). Avoid freezing.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
2 presentations of Nystatin and Triamcinolone acetonide, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Nystatin and Triamcinolone acetonide 100000 units/1 mg per g creamTopicalGeneric name | Nystatin and Triamcinolone acetonide | — | US FDA | Available on request |
| Nystatin and Triamcinolone acetonide 100000 units/1 mg per g ointmentTopicalGeneric name | Nystatin and Triamcinolone acetonide | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 2 presentations of Nystatin and Triamcinolone acetonide and sources them for licensed hospitals, importers and physicians against valid import documents.
No listed presentation of Nystatin and Triamcinolone acetonide is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.